Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]DOPA PET Predictors of Amisulpride Response in Psychosis
NCT02880995Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2017
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Open-label trial of amisulpride in schizophrenia, schizoaffective disorder and schizophreniform disorder (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Influx constant of [18 fluorine(F)]DOPA PET. Status: unknown.
02
Drugs
amisulpride
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NCT02880995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880995.